Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 5, No 2S (2013): Special issue "Stroke" Management of patients with post-stroke dementia Abstract  similar documents
Svetlana Viktorovna Verbitskaya
"... the efficacy of central acetylcholinesterase inhibitors and the NMDA receptor antagonist akatinol memantine ..."
 
Vol 4, No 2S (2012): Сognitive and other neuropsychiatric disorders Cognitive impairments in patients with prior ischemic stroke Abstract  similar documents
V. A. Parfenov, M. A. Cherdak, N. V. Vakhnina, S. V. Verbitskaya, L. Yu. Nikitina
"... , and behavioral disorders. The experience with akatinol memantine used in postischemic dementia has been found ..."
 
Vol 6, No 2S (2014): Special issue "Stroke" NMDA receptor antagonists in the treatment of patients with vascular cognitive imprairments Abstract  similar documents
I.S. Preobrazhenskaya
"... The paper discusses the possibilities of using the NMDA receptor antagonist memantine in patients ..."
 
Vol 9, No 4 (2017) Current approaches to diagnosing and treating major neurocognitive disorder Abstract  similar documents
A. A. Kulesh, V. V. Shestakov
"... of akatinol memantine to treat this disorder and the issues related to the comprehensive management ..."
 
Vol 7, No 3 (2015) Treatment for Alzheimer's diseases Abstract  similar documents
Nina Arkadyevna Tyuvina, V. V. Balabanova
"... pathogenesis; therapy; acetylcholinesterase inhibitors; akatinol memantine. Contact: Nina Arkadyevna Tyuvina ..."
 
Vol 4, No 2S (2012): Сognitive and other neuropsychiatric disorders Akatinol in the treatment of noncognitive neuropsychological disorders in neurogeriatric diseases Abstract  similar documents
T. G. Voznesenskaya
"... dementia. Memantine (akatinol) therapy-induced changes in NNPDs are shown. It is emphasized ..."
 
Vol 8, No 2 (2016) Alzheimer's disease under the mask of stroke Abstract  similar documents
A. A. Naumenko, N. V. Vakhnina
"... that are unassociated with emotional problems and disturbance of consciousness. Akatinol memantine is a drug that can ..."
 
Vol 8, No 4 (2016) ALZHEIMER’S DISEASE: DIAGNOSIS AND TREATMENT Abstract  similar documents
A. A. Naumenko, D. O. Gromova, N. V. Trofimova, I. S. Preobrazhenskaya
"... -рецепторов; акатинол мемантин; гантенерумаб; нооторопная терапия; церебролизин; нелекарственные методы ..."
 
Vol 10, No 3 (2018) Alzheimer's disease: some pharmacological and non-pharmacological approaches to correcting neuropsychiatric disorders Abstract  similar documents
E. G. Mendelevich
"... . The possibilities of drug therapy for NPDs are demonstrated. The role of akatinol memantine in correcting a number ..."
 
Vol 6, No 1 (2014) Dementia of the Alzheimer type: current state of the problem Abstract  similar documents
N.A. Tyuvina, V.V. Balabanova
"... , единственным представителем которых является Акатинол мемантин®. Теоретически терапевтическую активность ..."
 
Vol 7, No 1 (2015) Outpatient management of patients with dyscirculatory encephalopathy Abstract  similar documents
V. A. Parfenov, D. V. Neverovsky
"... at preventing stroke and improving cognitive functions; moreover, akatinol memantine was noted to be effective ..."
 
Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания Non-drug therapies for cognitive impairment Abstract  similar documents
I. S. Preobrazhenskaya, D. Fantalis, S. A. Abdyshova, A. A. Kindarova
 
Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания Alzheimer's disease Abstract  similar documents
N. N. Koberskaya
"... for AD. The efficacy of memantine (akatinol memantine) and the expediency of its use at different stages ..."
 
Vol 4, No 1 (2012) Lewy body dementia: clinical manifestations, diagnosis, and treatment Abstract  similar documents
Irina Sergeyevna Preobrazhenskaya
"... with basic symptomatic therapy are given. The results of the clinical trial of the activity of akatinol ..."
 
Vol 5, No 1 (2013) Mild and moderate cognitive impairments: clinical manifestations, etiology, pathogenesis, treatment approaches Abstract  similar documents
Irina Sergeyevna Preobrazhenskaya
"... of an interregional study of the efficacy of akatinol memantine in patients with MCI of varying etiology are given. ..."
 
Vol 10, No 1 (2018) Sleep disorders and Alzheimer’s disease Abstract  similar documents
A. N. Bogolepova
"... and treating sleep disorders in patients with AD. Akatinol memantine is one of the drugs with proven efficacy ..."
 
Vol 6, No 3 (2014) Alcohol abuse and related disorders treatment of alcohol dependence Abstract  similar documents
Yu. P. Sivolap
"... these agents, nalmefene that is being registered in Russia. Memantine and a number of other medications ..."
 
Vol 9, No 3 (2017) Current views of the risk factors, diagnosis, and therapy of Alzheimer's disease (according to the proceedings of the Alzheimer's Association International Conference, London, 2017) Abstract  similar documents
N. N. Koberskaya
 
Vol 6, No 1 (2014) Severe dementia: diagnosis, patient management, prevention of complications Abstract  similar documents
A.B. Lokshina
"... dementia with acetylcholinesterase inhibitors and/or a competitive blocker of the NMDA-receptor, memantine ..."
 
Vol 11, No 2 (2019) Vascular factors in the genesis of dementia and the optimization of patient management Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov
 
Vol 10, No 4 (2018) Cognitive and motor training for patients with moderate cognitive impairment and mild dementia Abstract  similar documents
A. A. Naumenko, I. S. Preobrazhenskaya
 
Vol 5, No 4 (2013) Dementia: epidemiology, clinical picture, diagnosis, approaches to therapy Abstract  similar documents
Irina Sergeyevna Preobrazhenskaya
"... to the pathogenetic therapy for dementia and the efficiency and safety of using NMDA receptor antagonists in patients ..."
 
Vol 3, No 4 (2011) Current therapy for cognitive impairments Abstract  similar documents
Natalia Vasilyevna Vakhnina
"... for the use of memantine and/or acetylcholinergic agents, i.e. basic therapy for the most common forms ..."
 
Vol 7, No 1 (2015) Current therapy for chronic cerebrovascular attack Abstract  similar documents
A. A. Shmonin, V. S. Krasnov, I. A. Shmonina, E. V. Melnikova
"... , donepezil) and a reversible NMDA receptor blocker (memantine) are symptomatically used at a stage ..."
 
Vol 10, No 2 (2018) Current management tactics for patients with dementia Abstract  similar documents
A. V. Medvedeva, O. V. Kosivtsova, K. A. Makhinov
"... inhibitors and N-methyl-D-aspartate (NMDA) glutamate receptor antagonists. Atypical neuroleptics are employed ..."
 
Vol 7, No 4 (2015) Neurological disorders in hypertensive patients Abstract  similar documents
N. V. Vakhnina, O. V. Milovanova, V. V. Grinyuk
"... блокатор НМДА-рецепторов к глютамату акатинол мемантин. Х а р а к т е р и с т и к а к л и н и ч е с к и ..."
 
Vol 9, No 2 (2017) Cognitive and non-cognitive neuropsychiatric disorders in dementia and methods of their correction Abstract  similar documents
E. G. Mendelevich
"... ; мемантин при лечении деменции с телами Леви – А [49]. Акатинол мемантин представляет собой обратимый ..."
 
Vol 2, No 1 (2010) VASCULAR DEMENTIA Abstract  similar documents
Maria Alekseyevna Cherdak, O V Uspenskaya
"... антагонистов NMDA-рецепторов (Ака- тинол Мемантин) оправдано, учитывая их способность уменьшать выраженность ..."
 
Vol 4, No 2S (2012): Сognitive and other neuropsychiatric disorders Mental disorders in Huntington’s disease Abstract  similar documents
S. A. Klyushnikov, E. N. Yudina, S. N. Illarioshkin, I. A. Ivanova-Smolenskaya
"... - грессирование деменции. Мы применяем акатинол мемантин (Merz, Германия) в суточной дозе 20 мг (по 10 мг 2 раза в ..."
 
Vol 5, No 2S (2013): Special issue "Stroke" Management of a post-stroke patient Abstract  similar documents
Vladimir Anatolyevich Parfenov, S V Verbitskaya
"... ]. Акатинол (мемантин) – антагонист NMDA-рецеп- торов – способен уменьшить проявления лобно-под- корковой ..."
 
Vol 6, No 4 (2014) Cognitive impairments in cerebrovascular disease Abstract  similar documents
A. Yu. Emelin
"... акатинол (ме- мантин) [38, 39]. Во многих клинических исследованиях по- казана способность мемантина ..."
 
Vol 5, No 4 (2013) Outpatient management after severe stroke with dementia Abstract  similar documents
Natalia Vyacheslavovna Pizova
"... центральных холинергических структур [49]. Акатинол (мемантин) – ан- тагонист NMDA-рецепторов – способен ..."
 
Vol 6, No 1 (2014) Vascular cognitive impairment Abstract  similar documents
N.V. Vakhnina
"... мемантина основано на прямой селективной блокаде патологически возбужденных NMDA-рецепторов с уменьшением ..."
 
Vol 6, No 2S (2014): Special issue "Stroke" Arterial hypertension and stroke: cardiac and neurological aspects of secondary prevention Abstract  similar documents
L.A. Geraskina
"... акатинола мемантина способствовало положи- тельной динамике основных компонентов постинсультных СКН, включая ..."
 
Vol 4, No 2 (2012) Evolution of cognitive deficit: mild and moderate cognitive impairments Abstract  similar documents
V V Zakharov
"... практике используется обратимый блокатор пост- синаптических НМДА-рецепторов акатинол мемантин, ко- торый ..."
 
Vol 6, No 1S (2014): Special issue "Epilepsy" Genetics of Epilepsy: What for and How to Examine Children with Epilepsy E.D. Belousova Abstract  similar documents
E. D. Belousova
"... the alpha subunit of NMDA receptors was muted in 17.6% of children with this syndrome. The need ..."
 
Vol 2, No 3 (2010) Dyscirculatory encephalopathy: algorithm for diagnosis and treatment in patients with arterialhypertension Abstract  similar documents
A S Kadykov, NataliaVladimirovna Shakhparonova
"... препараты нейромедин и галан- тамин, антагонист NMDA-рецепторов мемантин [5, 20, 21]. Имеются сведения об ..."
 
Vol 7, No 4 (2015) Some aspects of treatment for cognitive impairments. Cyticolin: pharmacological characteristics, possible benefits, aspects of use Abstract  similar documents
N. V. Trofimova, I. S. Preobrazhenskaya
"... N-метил-D-аспартату (антагонисты NMDA-рецепторов, акатинол мемантин) [1, 7, 11]. У пациентов с ..."
 
Vol 3, No 4 (2011) Actual directions in the primary prevention of ischemic stroke Abstract  similar documents
Andrei Viktorovich Fonyakin, L A Geraskina
"... . Дамулин И.В. Новая нейропротективная и терапевтическая стратегия при деменци- ях: антагонист NMDA ..."
 
Vol 9, No 1 (2017) The clinical features, diagnosis, and treatment of cognitive impairments in Parkinson's disease Abstract  similar documents
G. N. Akhmadeeva, R. V. Magzhanov, G. N. Tayupova, A. R. Baitimerov
"... донепезил), а также антагонист NMDA- рецепторов (мемантин) во многом благодаря тому, что они предназначены ..."
 
Vol 3, No 4 (2011) New possibilities of neuroprotection in ischemic stroke Abstract  similar documents
D V Sergeyev, M A Piradov, M Yu Maksimova, Maksim Alekseyevich Domashenko, A N Sergeyeva, F R Okhtova
"... исследования гипотермии, NXY- 059, антагониста NMDA-рецепторов ARL15896 и основно- го фактора роста ..."
 
Vol 10, No 2 (2018) Parkinson's disease and polymorphisms of the glutamatergic system genes GRIN2A, SLC1A2, and GRIK4 Abstract  similar documents
Yu. S. Mironova, I. A. Zhukova, N. G. Zhukova, S. A. Ivanova, V. M. Alifirova, A. S. Boiko, D. Z. Osmanova, O. P. Izhboldina, A. V. Latypova
"... with the polymorphic variants of glutamatergic system genes, such as GRIN2A encoding the N-methyl-D-aspartate (NMDA ..."
 
Vol 8, No 4 (2016) ISSUES OF THE ACCOUNTING OF A WEAK NEUROTRANSMITTER COMPONENT IN THE PHARMACOTHERAPY OF POSTCOMATOSE STATES Abstract  similar documents
O. S. Zaitsev, S. V. Tsarenko, M. V. Chelyapina, E. V. Sharova, E. V. Alexandrova, A. A. Potapov
"... поражении подкорковых образований, анти- глутаматные (акатинол мемантин) и ГАМКергические сред- ства ..."
 
Vol 5, No 2 (2013) The key areas of medical therapy for ischemic stroke Abstract  similar documents
Andrei Viktorovich Fonyakin, L A Geraskina
"... хрониче- скими цереброваскулярными заболеваниями [51, 52]. Ис- пользование антагониста NMDA-рецепторов ..."
 
Vol 1, No 2 (2009) NERVOUS AND MENTAL DISORDERS OF PARKINSON'S DISEASE Abstract  similar documents
Marina Romanovna Nodel', N N Yakhno, Marina Romanovna Nodel, N N Yakhno
"... расстройств. В случаях деменции показаны ин- гибитор АХЭ ривастигмин, антагонист NMDA-рецепторов акатинол ..."
 
Vol 3, No 1 (2011) Cognitive disorders in patients with essential hypertension and their treatment  similar documents
Vladimir Anatol'evich Parfenov, Yu A Starchina, Vladimir Anatolyevich Parfenov, Yu A Starchina
"... переносимой. Акатинола мемантин назнача- ют в дозе 5 мг/сут однократно, на 2-й неделе – по 5 мг/сут 2 раза ..."
 
Vol 6, No 2 (2014) Predementia states and dementia in young people Abstract  similar documents
A.A. Smirnov, A.V. Gustov, S.V. Kopishinskaya, V.A. Antonova
"... акатинол мемантин по 10 мг 2 раза в сутки. Что касается дегенеративных заболеваний, сопрово- ждающихся ..."
 
Vol 4, No 2S (2012): Сognitive and other neuropsychiatric disorders Alzheimer’s disease: diagnosis and treatment Abstract  similar documents
I. S. Preobrazhenskaya
"... фармакотерапевтической группы — антагонистов NMDA-рецепторов в отношении когнитивных симптомов у пациентов с БА. Позднее ..."
 
Vol 3, No 3 (2011) Prevention of Alzheimer's disease  similar documents
Vladimir Anatolyevich Parfenov
"... (га- лантамин, донепизил, ривастигмин) и акатинол (мемантин) эффективны для улучшения памяти и других ..."
 
Vol 4, No 2S (2012): Сognitive and other neuropsychiatric disorders Cognitive and neuropsychiatric disorders in extrapyramidal diseases Abstract  similar documents
O. S. Levin, M. A. Anikin, E. E. Vasenina
"... L.S. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a ..."
 
1 - 50 of 109 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)